Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span

R Azziz, C Marin, L Hoq… - The Journal of Clinical …, 2005 - academic.oup.com
Context: The polycystic ovary syndrome (PCOS) is the most common endocrine abnormality
of reproductive-aged women today, affecting approximately 6.6% of unselected reproductive …

The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome

HF Escobar-Morreale, M Luque-Ramírez… - Endocrine …, 2005 - academic.oup.com
The genetic mechanisms underlying functional hyperandrogenism and the polycystic ovary
syndrome (PCOS) remain largely unknown. Given the large number of genetic variants …

Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome

S Elsenbruch, S Hahn, D Kowalsky… - The Journal of …, 2003 - academic.oup.com
Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by
chronic anovulation and hyperandrogenism. PCOS is one of the leading causes of infertility …

Polycystic ovary syndrome and cardiovascular disease: a premature association?

RS Legro - Endocrine reviews, 2003 - academic.oup.com
Women with polycystic ovary syndrome (PCOS) are often assumed, a priori, to be at
increased risk for cardiovascular disease (CVD), given the high prevalence of the metabolic …

Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome

R Hart, M Hickey, S Franks - Best Practice & Research Clinical Obstetrics & …, 2004 - Elsevier
Polycystic ovarian morphology is seen on ultrasound in approximately 22% of women.
Polycystic ovary syndrome (PCOS) is a common and perplexing endocrine disorder of …

Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease

N Boulman, Y Levy, R Leiba, S Shachar… - The Journal of …, 2004 - academic.oup.com
The polycystic ovary syndrome (PCOS), one of the most common reproductive
abnormalities, shares some components of the metabolic cardiovascular syndrome …

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

CJ Glueck, R Papanna, P Wang, N Goldenberg… - Metabolism, 2003 - Elsevier
In 138 oligo-amenorrheic white women with polycystic ovary syndrome (PCOS)(31±9-years-
old), our first specific aim was to assess the incidence of the metabolic syndrome and to …

Sex hormone–binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women …

K Sutton-Tyrrell, RP Wildman, KA Matthews, C Chae… - Circulation, 2005 - Am Heart Assoc
Background—Recent clinical trials have shifted attention away from estrogens and toward
androgens and sex hormone–binding globulin (SHBG) as potential mediators of increasing …

Insulin-lowering agents in the management of polycystic ovary syndrome

V De Leo, A La Marca, F Petraglia - Endocrine reviews, 2003 - academic.oup.com
Polycystic ovary syndrome (PCOS) is a medical condition that has brought multiple
specialists together. Gynecologists, endocrinologists, cardiologists, pediatricians, and …

Polycystic ovary syndrome

DS Guzick - Obstetrics & Gynecology, 2004 - journals.lww.com
Women with polycystic ovarian syndrome have chronic anovulation and androgen excess
not attributable to another cause. This condition occurs in approximately 4% of women. The …